MedPath

Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression

Not Applicable
Completed
Conditions
Pancreatic Cancer
Obstructive Jaundice
Interventions
Procedure: Stent Dysfunction
Procedure: Complications
Registration Number
NCT01675908
Lead Sponsor
AdventHealth
Brief Summary

Compare the performance of full covered metal stents and plastic stents for preoperative biliary decompression

Detailed Description

Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr plastic stents. When compared to plastic stents, randomized trials have shown longer patency and fewer stent-related complications for CSEMS. The investigators hypothesize that placement of CSEMS would be a better treatment option for preoperative biliary decompression in patients with pancreatic cancer.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Metal stentComplicationsPatients randomized to one cohort will undergo placement of fully covered self expandable metal stents. The rates (%) of stent dysfunction and complications will be evaluated.
Metal stentStent DysfunctionPatients randomized to one cohort will undergo placement of fully covered self expandable metal stents. The rates (%) of stent dysfunction and complications will be evaluated.
Plastic StentComplicationsAt ERCP, a 10Fr plastic stent will be placed in the bile duct. The rates (%) of stent dysfunction and complications will be evaluated.
Plastic StentStent DysfunctionAt ERCP, a 10Fr plastic stent will be placed in the bile duct. The rates (%) of stent dysfunction and complications will be evaluated.
Primary Outcome Measures
NameTimeMethod
Complications related to stent dysfunction30 days

Evaluate the rates of complications (%) related to stent dysfunction which include persistent hyperbilirubinemia and cholangitis that warrant stent exchange by a repeat ERCP.

Secondary Outcome Measures
NameTimeMethod
Procedural complications30 days

This will be measured as proportion of patients who encounter a procedural complication (%) during ERCP that includes pancreatitis, perforation or hemorrhage.

Trial Locations

Locations (1)

Florida Hospital

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath